Eli Lilly issued an open letter in June about counterfeit and poorly compounded versions of Mounjaro and Zepbound, its injected diabetes and obesity treatments. Watch to learn what Lilly said about the dangers to patients, and make sure that you and you loved ones are getting safe treatments.
More Episodes
Black Market Med Scammers Back At It
2024-09-20
2
2024-09-20
2
Virginia Med Spa Owner Pleads Guilty
2024-09-16
2024-09-16
September 4, 2024: FDA Alert: Dosing Errors
2024-09-05
2
2024-09-05
2
DCA: Fungus-Contaminated Injections in India
2024-08-22
6
2024-08-22
6
Understand the Real Story of Compounded Semaglutide
2024-07-31
8
2024-07-31
8
New FDA Rule to Clear the Clog of Counterfeits
2024-07-31
3
2024-07-31
3
Pill Press Legislation Introduced
2024-07-17
10
2024-07-17
10
Semaglutide drugs on the web may not be real
2024-07-11
3
2024-07-11
3
Learn about the DEA's Reporting on Counterfeit Drugs
2024-07-11
4
2024-07-11
4
Injectable Meds Bought from TikTok
2024-07-08
3
2024-07-08
3
The Danger of Fake Botox
2024-07-01
4
2024-07-01
4
Counterfeit Botox in Mexico
2024-06-20
6
2024-06-20
6
Medicine Recalls Under DSCSA
2024-05-27
3
2024-05-27
3
DEA's Pill Press Push
2024-05-22
4
2024-05-22
4
FDA Warns about Unapproved Lidocaine Products
2024-05-20
3
2024-05-20
3
Case Closed: 9 Years in Prison
2024-05-15
7
2024-05-15
7
May 8, 2024: Feds sentence online tapentadol seller
2024-05-08
7
2024-05-08
7
Get this podcast on your
phone, FREE
